Portable ultra-low-field MRI in acute stroke care: A pilot study
1Department of Vascular Neurology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.
Related Experiment Videos
View abstract on PubMed
Summary
Portable ultra-low field (pULF) MRI shows promise for diagnosing stroke, especially where high-field MRI is unavailable. This pilot study found pULF-MRI guided treatment decisions accurately in acute stroke patients.
Area of Science:
- Neurology
- Medical Imaging
- Stroke Medicine
Background:
- Neuroimaging is crucial for stroke treatment but lacks global accessibility.
- Portable ultra-low field (pULF) MRI offers potential to expand access to neuroimaging and improve worldwide stroke care.
- This pilot study introduces pULF-MRI in a European stroke center, comparing its diagnostic utility to high-field (HF) MRI.
Purpose of the Study:
- To evaluate the diagnostic accuracy of pULF-MRI compared to HF-MRI in patients with suspected ischemic stroke.
- To assess the reliability of pULF-MRI for making imaging-based therapeutic decisions.
- To determine the potential role of pULF-MRI in acute stroke care, particularly in resource-limited settings.
Main Methods:
- Seventeen patients with suspected ischemic stroke underwent pULF-MRI (0.064 Tesla Swoop system) alongside standard imaging.
- Scans from both pULF-MRI and HF-MRI were independently assessed by blinded reviewers.
- Diagnostic accuracy and treatment decisions based on pULF-MRI were compared to those based on HF-MRI.
Main Results:
- Ischemic lesions were identified on HF-MRI in 12 out of 17 patients.
- pULF-MRI detected ischemic lesions in 8 of these 12 cases; missed infarcts were small (<6mm).
- Treatment decisions based on pULF-MRI imaging consistently matched actual clinical decisions.
Conclusions:
- pULF-MRI is a promising tool for acute stroke care, offering reliable imaging for treatment decisions and monitoring.
- pULF-MRI can support stroke care when HF-MRI is inaccessible, especially in resource-limited environments.
- Limitations include longer scan times and absence of vessel imaging and hemorrhage-sensitive sequences.